Your browser is no longer supported. Please, upgrade your browser.
CFX [NYSE]
Colfax Corporation
Index- P/E86.12 EPS (ttm)0.51 Insider Own1.40% Shs Outstand139.60M Perf Week2.21%
Market Cap5.92B Forward P/E17.90 EPS next Y2.45 Insider Trans-6.28% Shs Float100.51M Perf Month-1.15%
Income72.90M PEG3.99 EPS next Q0.53 Inst Own88.50% Short Float14.47% Perf Quarter7.73%
Sales3.13B P/S1.89 EPS this Y532.80% Inst Trans-0.76% Short Ratio9.07 Perf Half Y30.33%
Book/sh30.42 P/B1.44 EPS next Y14.35% ROA0.80% Target Price52.36 Perf Year78.90%
Cash/sh5.66 P/C7.76 EPS next 5Y21.57% ROE1.60% 52W Range22.35 - 50.26 Perf YTD14.85%
Dividend- P/FCF26.69 EPS past 5Y-20.90% ROI2.80% 52W High-12.61% Beta2.21
Dividend %- Quick Ratio0.90 Sales past 5Y-2.20% Gross Margin42.00% 52W Low96.51% ATR1.23
Employees15400 Current Ratio1.30 Sales Q/Q7.70% Oper. Margin5.60% RSI (14)51.52 Volatility2.95% 2.75%
OptionableYes Debt/Eq0.52 EPS Q/Q238.00% Profit Margin1.80% Rel Volume0.85 Prev Close42.14
ShortableYes LT Debt/Eq0.35 EarningsApr 29 BMO Payout0.00% Avg Volume1.60M Price43.92
Recom2.10 SMA200.02% SMA50-2.25% SMA20016.14% Volume1,362,318 Change4.22%
Apr-06-21Downgrade Barclays Equal Weight → Underweight $48 → $45
Nov-09-20Upgrade UBS Neutral → Buy $36 → $40
Sep-16-20Initiated UBS Neutral $36
May-29-20Initiated JP Morgan Overweight $32
May-11-20Upgrade Northcoast Neutral → Buy $38
Jan-16-20Resumed Goldman Buy $44
Dec-17-19Upgrade BofA/Merrill Neutral → Buy
Nov-27-19Resumed Barclays Equal Weight $36
Nov-04-19Upgrade BofA/Merrill Underperform → Neutral $27 → $37
Apr-05-19Resumed Goldman Buy
Sep-04-18Upgrade Oppenheimer Perform → Outperform
Aug-21-18Initiated Morgan Stanley Equal-Weight $34
Jun-04-18Downgrade BofA/Merrill Buy → Underperform
May-04-18Downgrade RBC Capital Mkts Outperform → Sector Perform
Feb-15-18Initiated Barclays Underweight $29
Feb-07-18Upgrade Gabelli & Co Hold → Buy
Feb-07-18Reiterated Stifel Buy $48 → $40
Jan-16-18Reiterated Stifel Buy $44 → $48
Nov-21-17Upgrade Longbow Neutral → Buy
Aug-25-17Upgrade KeyBanc Capital Mkts Sector Weight → Overweight
May-13-21 03:04AM  
Apr-30-21 11:55AM  
Apr-29-21 06:00AM  
05:45AM  
Apr-27-21 12:10PM  
Apr-26-21 07:00AM  
Apr-22-21 12:33PM  
Apr-14-21 01:07PM  
Apr-12-21 03:51PM  
Apr-07-21 03:01AM  
Mar-30-21 07:00AM  
Mar-26-21 09:36AM  
Mar-25-21 06:00AM  
Mar-16-21 11:30PM  
12:54PM  
Mar-15-21 04:05PM  
Mar-08-21 01:52PM  
Mar-05-21 06:52AM  
Mar-04-21 06:41AM  
06:35AM  
06:00AM  
Feb-22-21 04:45PM  
Feb-21-21 02:04AM  
Feb-18-21 01:30PM  
07:46AM  
06:15AM  
06:00AM  
Jan-29-21 01:40PM  
Jan-21-21 09:24AM  
Jan-19-21 07:00PM  
Jan-13-21 09:38AM  
Jan-08-21 02:14PM  
Jan-06-21 01:13AM  
Dec-14-20 02:38PM  
09:09AM  
Dec-11-20 08:00AM  
Nov-27-20 10:02AM  
Nov-24-20 02:25PM  
Nov-13-20 09:24AM  
Nov-12-20 08:00AM  
Nov-07-20 08:43AM  
Nov-03-20 01:16PM  
Oct-30-20 11:58AM  
Oct-29-20 07:30AM  
06:00AM  
06:00AM  
Oct-22-20 12:34PM  
Oct-17-20 07:12AM  
Oct-14-20 09:13AM  
Oct-12-20 09:55AM  
Oct-09-20 09:00AM  
Sep-30-20 09:29AM  
Sep-25-20 02:11PM  
Sep-11-20 08:04AM  
Sep-08-20 08:11PM  
Sep-05-20 11:31AM  
Aug-20-20 07:00AM  
Aug-10-20 10:01AM  
10:01AM  
Aug-07-20 11:38AM  
Aug-06-20 04:45PM  
08:55AM  
06:00AM  
Jul-30-20 12:33PM  
Jul-20-20 08:27AM  
Jul-17-20 12:10PM  
Jul-14-20 01:55PM  
01:55PM  
Jul-13-20 08:25PM  
Jun-16-20 12:20PM  
Jun-06-20 11:31AM  
Jun-05-20 11:56AM  
Jun-01-20 08:00AM  
May-29-20 09:49AM  
May-27-20 09:45AM  
May-13-20 11:06AM  
May-12-20 12:31PM  
09:00AM  
May-08-20 10:24AM  
May-07-20 10:30PM  
07:45AM  
06:00AM  
May-06-20 10:31AM  
Apr-30-20 12:34PM  
Apr-28-20 09:16AM  
Apr-27-20 02:16PM  
Apr-26-20 09:35AM  
Apr-23-20 11:19AM  
Apr-03-20 03:38PM  
Mar-28-20 09:34PM  
Mar-27-20 07:45AM  
06:57AM  
Mar-23-20 11:50AM  
08:38AM  
Mar-22-20 11:30AM  
Mar-13-20 04:47PM  
Mar-12-20 10:19AM  
Mar-09-20 12:13PM  
Mar-06-20 03:41AM  
Feb-27-20 09:35AM  
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the infrastructure, wind power, marine/life sciences, pipelines, mobile/off-highway equipment, oil, gas, and mining markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and direct and independent distributors under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Annapolis Junction, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lang Patricia ASVP, Chief HR OfficerMay 03Option Exercise26.8824,677663,31843,218May 04 08:00 PM
Lang Patricia ASVP, Chief HR OfficerMay 03Sale43.9424,6771,084,30718,541May 04 08:00 PM
PRYOR DANIEL AEVP, Strategy & Business Dev.Mar 10Sale47.7336,0621,721,290164,257Mar 11 09:00 PM
Kambeyanda ShyamESAB President and EVP, ColfaxMar 10Sale46.7411,897556,06692,545Mar 11 09:00 PM
Hix Christopher MEVP, Chief Financial OfficerMar 10Sale46.7418,206850,94892,800Mar 11 09:00 PM
Tandy Bradley JSVP, General CounselFeb 26Sale44.993,536159,08510,619Mar 01 09:01 PM
Kambeyanda ShyamESAB President and EVP, ColfaxFeb 25Sale46.011,85085,11862,389Feb 26 09:01 PM
Trerotola Matthew L.President & CEOFeb 25Sale46.016,057278,683233,699Feb 26 09:00 PM
Lang Patricia ASVP, Chief HR OfficerFeb 25Sale46.0150723,3279,249Feb 26 09:01 PM
PRYOR DANIEL AEVP, Strategy & Business Dev.Feb 25Sale46.011,96190,226101,859Feb 26 09:01 PM
Tandy Bradley JSVP, General CounselFeb 25Sale46.0181537,49814,155Feb 26 09:00 PM
Hix Christopher MEVP, Chief Financial OfficerFeb 25Sale46.012,00792,34269,955Feb 26 09:00 PM
Trerotola Matthew L.President & CEOJan 05Sale38.1222,039840,181200,967Jan 07 07:00 PM
Kambeyanda ShyamESAB President and EVP, ColfaxDec 14Sale37.412,35788,17554,855Dec 15 08:00 PM
Hix Christopher MEVP, Chief Financial OfficerDec 14Sale37.414,483167,70959,449Dec 15 08:00 PM
MacLean JasonSVP, CBS & Supply ChainNov 09Sale33.111,00133,1437,814Nov 10 08:00 PM
Shirley BradyEVP, Colfax, Pres. & CEO, DJOOct 30Buy26.9510,000269,46862,226Dec 11 08:00 PM
MacLean JasonSVP, CBS & Supply ChainAug 12Sale35.322,49187,9828,815Aug 13 07:00 PM
Trerotola Matthew L.President & CEOJul 27Sale30.8319,481600,599223,006Jul 27 08:00 PM
Hix Christopher MEVP, Chief Financial OfficerJul 02Sale28.246,719189,74563,932Jul 02 06:00 PM
Vinnakota RajivDirectorJun 15Sale27.441,80049,39221,888Jun 16 07:00 PM